###begin article-title 0
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 71 74 <span type="species:ncbi:10116">rat</span>
P2X7 nucleotide receptors mediate caspase-8/9/3-dependent apoptosis in rat primary cortical neurons
###end article-title 0
###begin p 1
###xml 237 238 237 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 263 264 263 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 540 541 540 541 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 582 583 582 583 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 653 654 653 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 724 725 724 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1055 1056 1055 1056 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1516 1517 1516 1517 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 270 273 <span type="species:ncbi:10116">rat</span>
Apoptosis is a major cause of cell death in the nervous system. It plays a role in embryonic and early postnatal brain development and contributes to the pathology of neurodegenerative diseases. Here, we report that activation of the P2X7 nucleotide receptor (P2X7R) in rat primary cortical neurons (rPCNs) causes biochemical (i.e., caspase activation) and morphological (i.e., nuclear condensation and DNA fragmentation) changes characteristic of apoptotic cell death. Caspase-3 activation and DNA fragmentation in rPCNs induced by the P2X7R agonist BzATP were inhibited by the P2X7R antagonist oxidized ATP (oATP) or by pre-treatment of cells with P2X7R antisense oligonucleotide indicating a direct involvement of the P2X7R in nucleotide-induced neuronal cell death. Moreover, Z-DEVD-FMK, a specific and irreversible cell permeable inhibitor of caspase-3, prevented BzATP-induced apoptosis in rPCNs. In addition, a specific caspase-8 inhibitor, Ac-IETD-CHO, significantly attenuated BzATP-induced caspase-9 and caspase-3 activation, suggesting that P2X7R-mediated apoptosis in rPCNs occurs primarily through an intrinsic caspase-8/9/3 activation pathway. BzATP also induced the activation of C-jun N-terminal kinase 1 (JNK1) and extracellular signal-regulated kinases (ERK1/2) in rPCNs, and pharmacological inhibition of either JNK1 or ERK1/2 significantly reduced caspase activation by BzATP. Taken together, these data indicate that extracellular nucleotides mediate neuronal apoptosis through activation of P2X7Rs and their downstream signaling pathways involving JNK1, ERK and caspases 8/9/3.
###end p 1
###begin title 2
Key words
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 481 494 481 494 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1,2,4,6,11&#8211;14</sub>
###xml 534 537 534 537 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1&#8211;7</sub>
###xml 785 786 785 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 787 788 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
ATP is an important extracellular messenger generated from various sources including release from presynaptic vesicles upon nerve stimulation in the peripheral and central nervous systems [1]. Extracellular ATP functions as a neuromodulator by activation of cell surface P2 nucleotide receptors that are widely expressed in the nervous system [2, 3]. Based on their distinct structure, P2 nucleotide receptors are classified into two families: G protein-coupled P2Y receptors (P2YR1,2,4,6,11-14; 4) and ligand-gated ion channels (P2XR1-7; 5). Functional responses to activation of these P2 receptor subtypes in cells of the nervous system under normal and pathological conditions include cell apoptosis, proliferation and migration, inflammation, ion transport, and neurotransmission [5-9]. Therefore, P2 receptors in the nervous system may prove to be useful pharmaceutical targets in the treatment of neurological disorders.
###end p 4
###begin p 5
###xml 245 247 245 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 298 299 298 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 372 373 372 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 605 606 605 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 860 862 860 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 893 894 893 894 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 992 994 992 994 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1105 1107 1105 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 1113 1115 1113 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1117 1119 1117 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 1149 1150 1149 1150 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1236 1238 1236 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1240 1242 1240 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 1299 1301 1299 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 1325 1326 1325 1326 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1353 1355 1353 1355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1399 1401 1399 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 1438 1440 1438 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 1487 1488 1487 1488 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1505 1507 1505 1507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 1516 1523 1516 1523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 1570 1571 1570 1571 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1672 1674 1672 1674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 1767 1768 1767 1768 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1857 1859 1857 1859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 1869 1870 1869 1870 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1959 1961 1959 1961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 2000 2002 2000 2002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 2090 2091 2090 2091 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 2291 2292 2291 2292 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 2306 2308 2306 2308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 1499 1503 <span type="species:ncbi:10090">mice</span>
###xml 1838 1844 <span type="species:ncbi:10090">murine</span>
###xml 1929 1934 <span type="species:ncbi:9606">human</span>
###xml 1967 1972 <span type="species:ncbi:9606">human</span>
The seven subtypes of the ionotropic ATP-gated P2XR family, ranging from 379 to 595 amino acids in length, regulate the intracellular calcium concentration through ligand-stimulated increases in the cell membrane permeability to extracellular Ca2+ ions [10, 11]. In contrast to other P2XRs, the P2X7R subtype functions exclusively as a homomeric receptor [12, 13]. The P2X7R is a 595-amino acid polypeptide containing two membrane-spanning domains, a large extracellular loop, and intracellular N- and C-terminal domains including a C-terminal tail that is the longest among the cloned P2XRs [14, 15]. P2X7Rs have been reported in microglial cells [16] where they play a role in cytokine release [17]. These receptors are also found in cultured astrocytes and Schwann cells [18, 19], spinal cord neurons and in other regions of the central nervous system [20, 21]. Brief stimulation of the P2X7R with ATP results in formation of a non-selective cationic channel that promotes the influx of Ca2+ and the equilibration of the transmembrane sodium and potassium gradients leading to membrane depolarization [14, 15, 22, 23]. Subsequent responses to P2X7R activation include the formation of a nonselective pore for molecules up to 900 Da [22, 23], extensive membrane blebbing, and eventual cell death [23]. Activation of the P2X7R was reported to elicit Ca2+ influx in cerebrocortical nerve terminals [24] and hippocampal glutamate release [25], which has been confirmed by studies with P2X7R knockout mice [26]. In an ex vivo model of organotypic hippocampal cultures, P2X7R activation was shown to directly participate in cell damage induced by oxygen/glucose deprivation [27]. It has been shown that a Pro-451 to Leu polymorphism within the C-terminal tail of the P2X7R interferes with the ability of the receptor to induce cell death in murine thymocytes [28]. The P2X7R also has been shown to mediate ATP-induced cell death in human embryonic kidney cells [29] and human cervical epithelial cells [30]. A recent study demonstrated that spinal cord injury was associated with prolonged P2X7R activation of spinal cord neurons by extracellular ATP, which resulted in high-frequency spiking, increases in cytosolic calcium levels and neuronal degeneration, responses that were reversed by P2X7R inhibition [31].
###end p 5
###begin p 6
###xml 49 50 49 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 250 251 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 127 130 <span type="species:ncbi:10116">rat</span>
In the present study, we demonstrate that the P2X7R agonists BzATP or ATP induce nuclear condensation and DNA fragmentation in rat primary cortical neurons (rPCNs). These apoptotic responses in rPCNs were dependent on the functional expression of P2X7Rs that mediate the ERK1/2- and JNK1-dependent activation of caspases-8/9/3.
###end p 6
###begin title 7
Materials and methods
###end title 7
###begin title 8
Materials
###end title 8
###begin p 9
###xml 533 534 533 534 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1617 1624 1611 1618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In Situ</italic>
###xml 6 12 <span type="species:ncbi:9913">bovine</span>
###xml 313 319 <span type="species:ncbi:9986">Rabbit</span>
###xml 325 328 <span type="species:ncbi:10116">rat</span>
###xml 337 348 <span type="species:ncbi:3704">horseradish</span>
###xml 377 381 <span type="species:ncbi:9925">goat</span>
###xml 387 393 <span type="species:ncbi:9986">rabbit</span>
###xml 418 422 <span type="species:ncbi:9925">goat</span>
###xml 428 433 <span type="species:ncbi:10090">mouse</span>
###xml 516 520 <span type="species:ncbi:9925">Goat</span>
###xml 526 529 <span type="species:ncbi:10116">rat</span>
###xml 592 598 <span type="species:ncbi:9986">Rabbit</span>
###xml 604 607 <span type="species:ncbi:10116">rat</span>
###xml 686 691 <span type="species:ncbi:10090">Mouse</span>
###xml 797 801 <span type="species:ncbi:9925">goat</span>
###xml 807 812 <span type="species:ncbi:10090">mouse</span>
###xml 846 850 <span type="species:ncbi:9925">goat</span>
###xml 856 862 <span type="species:ncbi:9986">rabbit</span>
Fetal bovine serum (FBS) was obtained from Hyclone (Logan, UT, USA). Dulbecco's Modified Eagle's medium (DMEM), Minimum Essential Medium (MEM), Neurobasal medium, penicillin (100 units/ml), streptomycin (100 units/ml) and B27-AO (B27 without cortex antioxidants) were obtained from Gibco-BRL (Carlsbad, CA, USA). Rabbit anti-rat ERK1/2, horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG, and HRP-conjugated goat anti-mouse IgG antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Goat anti-rat P2X7R antibody was obtained from Alomone (Jerusalem, Israel). Rabbit anti-rat caspase-8 antibody was obtained from Biovision Inc. (Mountain View, CA, USA). Mouse anti-NeuN antibody was obtained from Chemicon International Inc. (Temecula, CA, USA). Alexa Fluor TM 488 goat anti-mouse IgG antibody, Alexa Fluor TM 594 goat anti-rabbit IgG antibody, YO-PRO-1, TO-PRO-3 and the Prolong(R) anti-fade kit were obtained from Molecular Probes Inc. (Eugene, OR, USA). All other antibodies were obtained from Cell Signaling Technology (Beverly, MA, USA). Caspase-3 and caspase-9 inhibitors were obtained from R&D (Minneapolis, MN, USA). Caspase-8 inhibitor was obtained from BioSource International Inc. (Camarillo, CA, USA). The Precision Plus Protein Standards and nitrocellulose membranes (0.45 microm) were obtained from Bio-Rad (Hercules, CA, USA). LumiGLO chemiluminescent substrates were obtained from New England Biolabs (Beverly, MA, USA). The RNeasy Mini Kit was obtained from Qiagen (Chatsworth, CA, USA). The Apoptotic DNA-ladder kit, the First Strand cDNA Synthesis kit and the TUNEL In Situ Cell Death Detection kit were obtained from Roche (Indianapolis, IN, USA). Nucleotides and all other biochemicals were obtained from Sigma Chemical Co. (St. Louis, MO, USA).
###end p 9
###begin title 10
Primary cell culture of cortical neurons
###end title 10
###begin p 11
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 727 728 713 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1049 1050 1025 1026 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 44 47 <span type="species:ncbi:10116">rat</span>
###xml 198 217 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
###xml 464 469 <span type="species:ncbi:9796">horse</span>
###xml 646 651 <span type="species:ncbi:9796">horse</span>
###xml 811 816 <span type="species:ncbi:9796">horse</span>
Experimental procedures for cell culture of rat primary cortical neurons (rPCNs) were carried out essentially as described by Suen et al. [32]. Briefly, cerebral cortices from 18-day-old embryos of Sprague-Dawley rats were removed and the meninges discarded. The brain tissue was mechanically dissociated in HGGMEM comprised of 1.78 g glucose, 100 IU/ml penicillin, 100 microg/ml streptomycin, 7.5 microg/ml fungizone, 2 mM glutamine in 88 ml of MEM and 10% (v/v) horse serum. The tissue clumps were dispersed with a 10 ml pipette and suspended in 6 ml of 0.25% (w/v) trypsin at 37 degreesC for 10 min. After incubation, 2 ml of heat-inactivated horse serum were added to block trypsin activity. Cells were centrifuged at 4000 g for 10 min at 4 degreesC and the pellet was suspended in ice-cold HGGMEM with 10% horse serum. The cell suspension was filtered through a sterilized 85 microm cell strainer (nylon membrane; Becton Dickinson, Franklin Lakes, NJ) and cells were counted and seeded into plastic culture plates that were precoated with poly-d-lysine. After 16-18 h and every 2-3 days thereafter, the medium was replaced with B27-AO Neurobasal medium (2 mM glutamine, 8.9 g glucose, 100 IU/ml penicillin, 100 microg/ml streptomycin, 7.5 mg/ml fungizone, 10 ml of B27 minus AO, and Neurobasal medium (Gibco-BRL) to 500 ml) and the neurons were ready for use after 7 days in culture.
###end p 11
###begin title 12
RT-PCR analysis of P2XR mRNA expression
###end title 12
###begin p 13
###xml 450 451 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 769 776 747 754 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table 1</label>
###xml 776 841 754 819 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="14">Sequence-specific oligonucleotide primers used for RT-PCR studies</p>
###xml 776 841 754 819 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="14">Sequence-specific oligonucleotide primers used for RT-PCR studies</p></caption>
###xml 841 858 819 836 <th xmlns:xlink="http://www.w3.org/1999/xlink">Receptor subtypes</th>
###xml 858 883 836 861 <th xmlns:xlink="http://www.w3.org/1999/xlink">Oligonucleotide sequences</th>
###xml 841 883 819 861 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>Receptor subtypes</th><th>Oligonucleotide sequences</th></tr>
###xml 841 883 819 861 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th>Receptor subtypes</th><th>Oligonucleotide sequences</th></tr></thead>
###xml 883 887 861 865 <td xmlns:xlink="http://www.w3.org/1999/xlink">P2X1</td>
###xml 887 887 865 865 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 883 887 861 865 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>P2X1</td><td/></tr>
###xml 887 894 865 872 <td xmlns:xlink="http://www.w3.org/1999/xlink">Forward</td>
###xml 894 926 872 904 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-AAC AGC ATC AGC TTT CCA CG-3&#8242;</td>
###xml 887 926 865 904 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Forward</td><td>5&#8242;-AAC AGC ATC AGC TTT CCA CG-3&#8242;</td></tr>
###xml 926 933 904 911 <td xmlns:xlink="http://www.w3.org/1999/xlink">Reverse</td>
###xml 933 965 911 943 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-TGT AGT AGT GCC TCT TAG GC-3&#8242;</td>
###xml 926 965 904 943 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Reverse</td><td>5&#8242;-TGT AGT AGT GCC TCT TAG GC-3&#8242;</td></tr>
###xml 968 969 946 947 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 965 969 943 947 <td xmlns:xlink="http://www.w3.org/1999/xlink">P2X<sub>2</sub></td>
###xml 969 969 947 947 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 965 969 943 947 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>P2X<sub>2</sub></td><td/></tr>
###xml 969 976 947 954 <td xmlns:xlink="http://www.w3.org/1999/xlink">Forward</td>
###xml 976 1008 954 986 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-ACC TGC CTC TCC GAC GCC GA-3&#8242;</td>
###xml 969 1008 947 986 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Forward</td><td>5&#8242;-ACC TGC CTC TCC GAC GCC GA-3&#8242;</td></tr>
###xml 1008 1015 986 993 <td xmlns:xlink="http://www.w3.org/1999/xlink">Reverse</td>
###xml 1015 1047 993 1025 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-GAA GTC AGA GCT GTG GCC AG-3&#8242;</td>
###xml 1008 1047 986 1025 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Reverse</td><td>5&#8242;-GAA GTC AGA GCT GTG GCC AG-3&#8242;</td></tr>
###xml 1050 1051 1028 1029 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1047 1051 1025 1029 <td xmlns:xlink="http://www.w3.org/1999/xlink">P2X<sub>3</sub></td>
###xml 1051 1051 1029 1029 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1047 1051 1025 1029 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>P2X<sub>3</sub></td><td/></tr>
###xml 1051 1058 1029 1036 <td xmlns:xlink="http://www.w3.org/1999/xlink">Forward</td>
###xml 1058 1089 1036 1067 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-CAA CTT CAG GTT TGC CAA A-3&#8242;</td>
###xml 1051 1089 1029 1067 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Forward</td><td>5&#8242;-CAA CTT CAG GTT TGC CAA A-3&#8242;</td></tr>
###xml 1089 1096 1067 1074 <td xmlns:xlink="http://www.w3.org/1999/xlink">Reverse</td>
###xml 1096 1128 1074 1106 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-TGA ACA GTG AGG GCC TAG AT-3&#8242;</td>
###xml 1089 1128 1067 1106 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Reverse</td><td>5&#8242;-TGA ACA GTG AGG GCC TAG AT-3&#8242;</td></tr>
###xml 1131 1132 1109 1110 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1128 1132 1106 1110 <td xmlns:xlink="http://www.w3.org/1999/xlink">P2X<sub>4</sub></td>
###xml 1132 1132 1110 1110 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1128 1132 1106 1110 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>P2X<sub>4</sub></td><td/></tr>
###xml 1132 1139 1110 1117 <td xmlns:xlink="http://www.w3.org/1999/xlink">Forward</td>
###xml 1139 1168 1117 1146 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-TAC GAC ACG CCG CGC ATC-3&#8242;</td>
###xml 1132 1168 1110 1146 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Forward</td><td>5&#8242;-TAC GAC ACG CCG CGC ATC-3&#8242;</td></tr>
###xml 1168 1175 1146 1153 <td xmlns:xlink="http://www.w3.org/1999/xlink">Reverse</td>
###xml 1175 1208 1153 1186 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-TGC ACG ATT TGA GGT AGG ACG-3&#8242;</td>
###xml 1168 1208 1146 1186 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Reverse</td><td>5&#8242;-TGC ACG ATT TGA GGT AGG ACG-3&#8242;</td></tr>
###xml 1211 1212 1189 1190 <sub xmlns:xlink="http://www.w3.org/1999/xlink">5</sub>
###xml 1208 1212 1186 1190 <td xmlns:xlink="http://www.w3.org/1999/xlink">P2X<sub>5</sub></td>
###xml 1212 1212 1190 1190 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1208 1212 1186 1190 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>P2X<sub>5</sub></td><td/></tr>
###xml 1212 1219 1190 1197 <td xmlns:xlink="http://www.w3.org/1999/xlink">Forward</td>
###xml 1219 1251 1197 1229 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-CAA AGT CCA TGC CAA CGG AT-3&#8242;</td>
###xml 1212 1251 1190 1229 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Forward</td><td>5&#8242;-CAA AGT CCA TGC CAA CGG AT-3&#8242;</td></tr>
###xml 1251 1258 1229 1236 <td xmlns:xlink="http://www.w3.org/1999/xlink">Reverse</td>
###xml 1258 1290 1236 1268 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-ACG GAA CTC TAC CCC ATT AG-3&#8242;</td>
###xml 1251 1290 1229 1268 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Reverse</td><td>5&#8242;-ACG GAA CTC TAC CCC ATT AG-3&#8242;</td></tr>
###xml 1293 1294 1271 1272 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 1290 1294 1268 1272 <td xmlns:xlink="http://www.w3.org/1999/xlink">P2X<sub>6</sub></td>
###xml 1294 1294 1272 1272 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1290 1294 1268 1272 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>P2X<sub>6</sub></td><td/></tr>
###xml 1294 1301 1272 1279 <td xmlns:xlink="http://www.w3.org/1999/xlink">Forward</td>
###xml 1301 1333 1279 1311 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-GTA GTG CTG TGC CCA GGA AA-3&#8242;</td>
###xml 1294 1333 1272 1311 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Forward</td><td>5&#8242;-GTA GTG CTG TGC CCA GGA AA-3&#8242;</td></tr>
###xml 1333 1340 1311 1318 <td xmlns:xlink="http://www.w3.org/1999/xlink">Reverse</td>
###xml 1340 1372 1318 1350 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-GGA CTC CAC GCC TGA GGC TG-3&#8242;</td>
###xml 1333 1372 1311 1350 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Reverse</td><td>5&#8242;-GGA CTC CAC GCC TGA GGC TG-3&#8242;</td></tr>
###xml 1375 1376 1353 1354 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1372 1376 1350 1354 <td xmlns:xlink="http://www.w3.org/1999/xlink">P2X<sub>7</sub></td>
###xml 1376 1376 1354 1354 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1372 1376 1350 1354 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>P2X<sub>7</sub></td><td/></tr>
###xml 1376 1383 1354 1361 <td xmlns:xlink="http://www.w3.org/1999/xlink">Forward</td>
###xml 1383 1420 1361 1398 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-ACA ATG TTG AGA AAC GGA CTC TGA-3&#8242;</td>
###xml 1376 1420 1354 1398 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Forward</td><td>5&#8242;-ACA ATG TTG AGA AAC GGA CTC TGA-3&#8242;</td></tr>
###xml 1420 1427 1398 1405 <td xmlns:xlink="http://www.w3.org/1999/xlink">Reverse</td>
###xml 1427 1464 1405 1442 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-CCG GCT GTT GGT GGA ATC CAC ATC-3&#8242;</td>
###xml 1420 1464 1398 1442 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Reverse</td><td>5&#8242;-CCG GCT GTT GGT GGA ATC CAC ATC-3&#8242;</td></tr>
###xml 1464 1469 1442 1447 <td xmlns:xlink="http://www.w3.org/1999/xlink">G3PDH</td>
###xml 1469 1469 1447 1447 <td xmlns:xlink="http://www.w3.org/1999/xlink"/>
###xml 1464 1469 1442 1447 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>G3PDH</td><td/></tr>
###xml 1469 1476 1447 1454 <td xmlns:xlink="http://www.w3.org/1999/xlink">Forward</td>
###xml 1476 1516 1454 1494 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-TGA AGG TCG GTG TCA ACG GAT TTG GC-3&#8242;</td>
###xml 1469 1516 1447 1494 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Forward</td><td>5&#8242;-TGA AGG TCG GTG TCA ACG GAT TTG GC-3&#8242;</td></tr>
###xml 1516 1523 1494 1501 <td xmlns:xlink="http://www.w3.org/1999/xlink">Reverse</td>
###xml 1523 1560 1501 1538 <td xmlns:xlink="http://www.w3.org/1999/xlink">5&#8242;-CAT GTA GGC CAT GAG GTC CAC CAC-3&#8242;</td>
###xml 1516 1560 1494 1538 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>Reverse</td><td>5&#8242;-CAT GTA GGC CAT GAG GTC CAC CAC-3&#8242;</td></tr>
###xml 883 1560 861 1538 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td>P2X1</td><td/></tr><tr><td>Forward</td><td>5&#8242;-AAC AGC ATC AGC TTT CCA CG-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-TGT AGT AGT GCC TCT TAG GC-3&#8242;</td></tr><tr><td>P2X<sub>2</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-ACC TGC CTC TCC GAC GCC GA-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-GAA GTC AGA GCT GTG GCC AG-3&#8242;</td></tr><tr><td>P2X<sub>3</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-CAA CTT CAG GTT TGC CAA A-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-TGA ACA GTG AGG GCC TAG AT-3&#8242;</td></tr><tr><td>P2X<sub>4</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-TAC GAC ACG CCG CGC ATC-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-TGC ACG ATT TGA GGT AGG ACG-3&#8242;</td></tr><tr><td>P2X<sub>5</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-CAA AGT CCA TGC CAA CGG AT-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-ACG GAA CTC TAC CCC ATT AG-3&#8242;</td></tr><tr><td>P2X<sub>6</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-GTA GTG CTG TGC CCA GGA AA-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-GGA CTC CAC GCC TGA GGC TG-3&#8242;</td></tr><tr><td>P2X<sub>7</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-ACA ATG TTG AGA AAC GGA CTC TGA-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-CCG GCT GTT GGT GGA ATC CAC ATC-3&#8242;</td></tr><tr><td>G3PDH</td><td/></tr><tr><td>Forward</td><td>5&#8242;-TGA AGG TCG GTG TCA ACG GAT TTG GC-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-CAT GTA GGC CAT GAG GTC CAC CAC-3&#8242;</td></tr></tbody>
###xml 841 1560 819 1538 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th>Receptor subtypes</th><th>Oligonucleotide sequences</th></tr></thead><tbody><tr><td>P2X1</td><td/></tr><tr><td>Forward</td><td>5&#8242;-AAC AGC ATC AGC TTT CCA CG-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-TGT AGT AGT GCC TCT TAG GC-3&#8242;</td></tr><tr><td>P2X<sub>2</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-ACC TGC CTC TCC GAC GCC GA-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-GAA GTC AGA GCT GTG GCC AG-3&#8242;</td></tr><tr><td>P2X<sub>3</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-CAA CTT CAG GTT TGC CAA A-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-TGA ACA GTG AGG GCC TAG AT-3&#8242;</td></tr><tr><td>P2X<sub>4</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-TAC GAC ACG CCG CGC ATC-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-TGC ACG ATT TGA GGT AGG ACG-3&#8242;</td></tr><tr><td>P2X<sub>5</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-CAA AGT CCA TGC CAA CGG AT-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-ACG GAA CTC TAC CCC ATT AG-3&#8242;</td></tr><tr><td>P2X<sub>6</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-GTA GTG CTG TGC CCA GGA AA-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-GGA CTC CAC GCC TGA GGC TG-3&#8242;</td></tr><tr><td>P2X<sub>7</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-ACA ATG TTG AGA AAC GGA CTC TGA-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-CCG GCT GTT GGT GGA ATC CAC ATC-3&#8242;</td></tr><tr><td>G3PDH</td><td/></tr><tr><td>Forward</td><td>5&#8242;-TGA AGG TCG GTG TCA ACG GAT TTG GC-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-CAT GTA GGC CAT GAG GTC CAC CAC-3&#8242;</td></tr></tbody></table>
###xml 769 1560 747 1538 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table 1</label><caption><p textid="14">Sequence-specific oligonucleotide primers used for RT-PCR studies</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Receptor subtypes</th><th>Oligonucleotide sequences</th></tr></thead><tbody><tr><td>P2X1</td><td/></tr><tr><td>Forward</td><td>5&#8242;-AAC AGC ATC AGC TTT CCA CG-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-TGT AGT AGT GCC TCT TAG GC-3&#8242;</td></tr><tr><td>P2X<sub>2</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-ACC TGC CTC TCC GAC GCC GA-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-GAA GTC AGA GCT GTG GCC AG-3&#8242;</td></tr><tr><td>P2X<sub>3</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-CAA CTT CAG GTT TGC CAA A-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-TGA ACA GTG AGG GCC TAG AT-3&#8242;</td></tr><tr><td>P2X<sub>4</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-TAC GAC ACG CCG CGC ATC-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-TGC ACG ATT TGA GGT AGG ACG-3&#8242;</td></tr><tr><td>P2X<sub>5</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-CAA AGT CCA TGC CAA CGG AT-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-ACG GAA CTC TAC CCC ATT AG-3&#8242;</td></tr><tr><td>P2X<sub>6</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-GTA GTG CTG TGC CCA GGA AA-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-GGA CTC CAC GCC TGA GGC TG-3&#8242;</td></tr><tr><td>P2X<sub>7</sub></td><td/></tr><tr><td>Forward</td><td>5&#8242;-ACA ATG TTG AGA AAC GGA CTC TGA-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-CCG GCT GTT GGT GGA ATC CAC ATC-3&#8242;</td></tr><tr><td>G3PDH</td><td/></tr><tr><td>Forward</td><td>5&#8242;-TGA AGG TCG GTG TCA ACG GAT TTG GC-3&#8242;</td></tr><tr><td>Reverse</td><td>5&#8242;-CAT GTA GGC CAT GAG GTC CAC CAC-3&#8242;</td></tr></tbody></table></table-wrap>
###xml 167 170 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
Total RNA was isolated from rPCNs using the RNeasy Mini Kit (Qiagen). cDNA was synthesized from the purified RNA using the First Strand cDNA Synthesis Kit for RT-PCR (AMV) (Roche). Five percent of the synthesized cDNA was used as a template in PCR reactions with the Expand High Fidelity PCR System (Roche). Specific 338 Q. Kong et al. oligonucleotide primers were designed to selectively amplify cDNA for individual P2XR subtypes, as shown in Table 1. The amplification was performed using 35 cycles of denaturation at 95 degreesC for 30 s, with annealing at 60 degreesC for 30 s and extension at 72 degreesC for 1 min. The resulting PCR products were resolved on a 1% (w/v) agarose gel containing 10 microg/ml ethidium bromide and photographed under UV illumination. Table 1Sequence-specific oligonucleotide primers used for RT-PCR studiesReceptor subtypesOligonucleotide sequencesP2X1Forward5'-AAC AGC ATC AGC TTT CCA CG-3'Reverse5'-TGT AGT AGT GCC TCT TAG GC-3'P2X2Forward5'-ACC TGC CTC TCC GAC GCC GA-3'Reverse5'-GAA GTC AGA GCT GTG GCC AG-3'P2X3Forward5'-CAA CTT CAG GTT TGC CAA A-3'Reverse5'-TGA ACA GTG AGG GCC TAG AT-3'P2X4Forward5'-TAC GAC ACG CCG CGC ATC-3'Reverse5'-TGC ACG ATT TGA GGT AGG ACG-3'P2X5Forward5'-CAA AGT CCA TGC CAA CGG AT-3'Reverse5'-ACG GAA CTC TAC CCC ATT AG-3'P2X6Forward5'-GTA GTG CTG TGC CCA GGA AA-3'Reverse5'-GGA CTC CAC GCC TGA GGC TG-3'P2X7Forward5'-ACA ATG TTG AGA AAC GGA CTC TGA-3'Reverse5'-CCG GCT GTT GGT GGA ATC CAC ATC-3'G3PDHForward5'-TGA AGG TCG GTG TCA ACG GAT TTG GC-3'Reverse5'-CAT GTA GGC CAT GAG GTC CAC CAC-3'
###end p 13
###begin p 14
Sequence-specific oligonucleotide primers used for RT-PCR studies
###end p 14
###begin title 15
Single cell calcium assay
###end title 15
###begin p 16
###xml 7 9 7 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 10 11 10 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 54 56 54 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 219 220 219 220 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 402 403 392 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 411 412 401 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 771 773 755 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 774 775 758 759 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 859 861 843 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 879 881 863 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 882 883 866 867 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 922 924 906 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 925 926 909 910 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 191 194 <span type="species:ncbi:10116">Rat</span>
The [Ca2+]i was quantified in single cells with the Ca2+-sensitive fluorescent dye fura-2, using an InCyt Dual-Wavelength Fluorescence Imaging System (Intracellular Imaging, Cincinnati, OH). Rat PCNs cultured on a poly-d-lysine-coated coverslip were incubated with 2.5 microM fura-2-acetoxymethylester at 37 degreesC for 30 min in physiological salt solution (PSS) containing (mM) NaCl 138, KCl 5, CaCl2 2, MgCl2 1, HEPES 10, glucose 10, pH 7.4, and washed with PSS. The coverslip with fura-2-loaded cells was positioned on the stage of an inverted epifluorescence microscope (Nikon; model TMD) and stimulated with agonists at 37 degreesC, as described in the figure legends. Cells were exposed to 340/380 nm light and fluorescence emission at 505 nm was converted to [Ca2+]i using a standard curve created with solutions containing known concentrations of Ca2+. Increases in [Ca2+]i were measured by subtracting basal [Ca2+]i from the maximum agonist-induced increase in [Ca2+]i. The percentage of cells that responded to ATP/BzATP was also determined. Viable cells were identified by responsiveness to carbachol and non-responding cells were eliminated.
###end p 16
###begin title 17
Detection of nuclear condensation
###end title 17
###begin p 18
###xml 59 60 59 60 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 718 720 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
Rat PCNs were cultured in B27-AO Neurobasal medium on poly-d-lysine-coated coverslips in 12-well plates until 50-70% confluence. After nucleotide treatments, medium was removed and cells were washed once and incubated with DAPI-methanol staining solution (1 microg/ml) for 15 min at 37 degreesC. The staining solution was removed and the cells were washed with methanol. The inverted coverslip was placed onto a microscope slide using glycerol as the mounting agent. Nuclear morphology was observed under a fluorescence microscope (Nikon, Eclipse TE300) with a 340/380 nm excitation filter and a LP 430 nm barrier filter. DAPI has an absorbance maximum at 340 nm and an emission maximum at 488 nm in aqueous solution [33].
###end p 18
###begin title 19
DNA laddering assay
###end title 19
###begin p 20
###xml 204 205 200 201 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 206 207 202 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 798 799 776 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 1462 1463 1426 1427 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
Rat PCNs were cultured in B27-AO Neurobasal medium in 100 mm dishes to 70% confluence, and incubated in serumfree medium overnight with or without BzATP. Then, rPCNs were treated for 2 h with 500 microM H2O2 and DNA was isolated using the Apoptotic DNA-ladder kit (Roche, Indianapolis, IN) according to the manufacturer's instructions. DNA also was isolated from lyophilized apoptotic U937 cell lysate (provided with the DNA-ladder assay kit) for use as a positive control. Briefly, the medium was replaced with 200 microl of PBS and 200 microl of binding buffer (6 M guanidine-HCl, 10 mM urea, 10 mM TrisYHCl, pH 4.4, 20% (v/v) Triton X-100). After 10 min at 15-25 degreesC, 100 microl of isopropanol was added and the samples were transferred to a filter tube and centrifuged for 1 min at 10,000 g (Spectrafuge 18 M, Labnet, Edison, NJ). The fluid in the collection tube was discarded and the upper filter column was washed with 500 microl of washing buffer (20 mM NaCl and 2 mM TrisYHCl, pH 7.5, 40% (v/v) ethanol) followed by centrifugation twice for 1 min at 13,000 g. After the residual washing buffer was removed, the DNA was eluted with 200 microl of pre-warmed (70 degreesC) elution buffer (10 mM Tris, pH 8.5). The concentration and purity of the eluted DNA was determined by measuring the optical density at 260 and 280 nm. DNA was electrophoresed in a 2% (w/v) agarose gel at 80 V for 1 h in TBE buffer (89 mM Tris base, 89 mM boric acid, 2 mM EDTANa2-salt, pH 8.3) and visualized under UV light.
###end p 20
###begin title 21
TUNEL assay
###end title 21
###begin p 22
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 39 40 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 130 131 130 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 132 133 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 255 262 255 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In Situ</italic>
After treatment with nucleotides or H2O2, rPCNs were fixed with fresh 4% (v/v) paraformaldehyde in PBS and treated with 3% (v/v) H2O2 in methanol to inhibit endogenous peroxidase activity. Then, DNA strand breaks in fixed cells were detected with a TUNEL In Situ Cell Death Detection kit (Roche) according to the manufacturer's instructions. The number of TUNEL-positive cells and the total cell number were determined by fluorescence (Nikon, Eclipse TE300) using an excitation wavelength in the range of 450-500 nm and a detection wavelength in the range of 515-565 nm (green) and light microscopy with cell counting, respectively, at 200x magnification.
###end p 22
###begin title 23
Application of P2X7 antisense oligonucleotide
###end title 23
###begin p 24
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR65">65</xref>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 133 134 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">7</italic>
###xml 133 134 133 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>7</italic></sub>
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
###xml 531 532 527 528 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 126 129 <span type="species:ncbi:10116">rat</span>
Antisense oligonucleotide treatment was performed as previously described [65]. Phosphorothioate-modified oligonucleotides to rat P2X7 were synthesized and purified by Integrated DNA Technologies (ADT, Coralville, IA, USA). Sequences were designed as follows: sense 5'-AGAGCGT GAATTACGGCACATCAA-3', antisense 5'-TTGATGGT GCCGTAATTCACGCTCT-3'. Sequences were checked for uniqueness with the National Center for Biotechnology Information's Basic Local Alignment Search Tool [34]. The rPCNs were incubated with 0.1 or 1 micromol/L P2X7 sense or antisense S-oligonucleotide for 6 h in serum-free medium containing 1.4% (v/v) DOTAP liposomal reagent (Roche Diagnostics). Fresh serum-free medium was added with or without BzATP, and cells were cultured for an additional 18 h.
###end p 24
###begin title 25
Western blot analysis
###end title 25
###begin p 26
###xml 958 959 934 935 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
###xml 1204 1210 <span type="species:ncbi:9986">rabbit</span>
###xml 1219 1224 <span type="species:ncbi:10090">mouse</span>
###xml 1580 1586 <span type="species:ncbi:9986">rabbit</span>
###xml 1721 1727 <span type="species:ncbi:9986">rabbit</span>
Rat PCNs cultured in 6-well plates were treated with 300 microM BzATP in the presence or absence of inhibitors as indicated. The cells were washed twice with ice-cold PBS, and lysed for 5 min in 200 microl of ice-cold lysis buffer (20 mM TrisYHCl, pH 7.5, 2% (w/v) sodium dodecyl sulfate (SDS), and 1 mM sodium orthovanadate). Lysate (30 microg of protein) was added to Laemmli sample buffer (187.5 mM TrisYHCl, pH 6.8, 6% (w/v) SDS, 1.8% (v/v) b-mercaptoethanol and 0.003% (w/v) bromophenol blue). Samples were heated for 5 min at 96-100 degreesC, and subjected to 7.5% (w/v) SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes for protein immunoblotting. After overnight blocking at 4 degreesC with 5% (w/v) fat-free milk in TBS-T (10 mM TrisYHCl, pH 7.4, 120 mM NaCl, and 0.1% (v/v) Tween-20), membranes were incubated with either 1:1000 dilution of anti-ERK1/2, anti-phospho-ERK1/2, anti-phospho-JNK, or anti-P2X7R antibodies for 2 h at room temperature, or 1:1000 dilution of anti-cleaved caspase-3, anti-caspase-3, anti-cleaved caspase-9, anti-caspase-9, or anti-caspase-8 antibodies overnight at 4 degreesC followed by incubation with HRP-conjugated anti-rabbit or anti-mouse IgG antibodies (1:1000 dilution in TBS-T containing 5% (w/v) fat-free milk) for 1 h at room temperature. For normalization of protein loading, the membranes were stripped of antibodies by incubation for 30 min at 60 degreesC in stripping buffer (62.5 mM TrisYHCl, pH 6.8, 100 mM 2-mercaptoethanol, and 2% (w/v) SDS), and re-probed with 1:2000 dilution of rabbit polyclonal anti-actin antibody (2 h at room temperature; Cytoskeleton, Denver, CO) followed by 1:2000 dilution of HRP-conjugated anti-rabbit IgG antibody (1 h at room temperature). Protein immunoreactivity was visualized on autoradiographic film using the LumiGlo Chemiluminescence System (New England BioLabs), according to the manufacturer's instructions. The protein bands detected on X-ray film were quantified using a computer-driven scanner and Quantity One software (Bio-Rad, Hercules, CA). The activation levels of kinases or caspases were calculated as a percentage of control (i.e., total kinase, caspase, or actin).
###end p 26
###begin title 27
Immunofluorescence
###end title 27
###begin p 28
###xml 131 135 <span type="species:ncbi:9925">goat</span>
###xml 215 220 <span type="species:ncbi:10090">mouse</span>
###xml 271 277 <span type="species:ncbi:9986">rabbit</span>
###xml 366 370 <span type="species:ncbi:9925">goat</span>
###xml 466 470 <span type="species:ncbi:9925">goat</span>
###xml 476 481 <span type="species:ncbi:10090">mouse</span>
###xml 502 506 <span type="species:ncbi:9925">goat</span>
###xml 512 518 <span type="species:ncbi:9986">rabbit</span>
###xml 613 617 <span type="species:ncbi:9925">goat</span>
After fixation and permeabilization, rPCNs cultured on coverslips in 6-well plates were incubated in 2.5% (w/v) BSA and 2.5% (v/v) goat serum in PBS for 1 h at room temperature followed by incubation overnight with mouse anti-NeuN antibody (1:100 dilution; Chemicon) and rabbit anti-cleaved caspase-3 antibody (1:100 dilution; Cell Signaling) in 0.25% BSA and 0.25% goat serum in PBS. Cells were washed three times with PBS and then incubated with 1:200 dilution of goat anti-mouse Alexa Fluor 488- or goat anti-rabbit Alexa Fluor 594-conjugated IgG antibody (Molecular Probes, Eugene, OR) in 0.25% BSA and 0.25% goat serum in PBS for 1 h at 37 degreesC. Nuclei were stained with TO-PRO-3 (Molecular Probes), cells were rinsed with PBS and mounted on glass slides in ProLong antifade reagent (Molecular Probes). Images were obtained on a Bio-Rad MRC 1024 laser scanning confocal imaging system coupled to an Olympus IX70 inverted microscope. The imaging system was controlled by Laser Sharp software (version 3.2; Bio-Rad, Hercules, CA). Alexa 488-labeled slices were excited by 488 nm laser light, and images were acquired with a 522 nm emission filter with a bandwidth of 35 nm, whereas Alexa 594-labeled slices were excited by 568 nm light and images acquired with a 585 nm longpass emission filter. Settings of the confocal microscope were optimized for imaging in an initial experiment and then equivalently applied to all sections. Laser power and photomultiplier tube (PMT) gain were adjusted to ensure that even the brightest fluorescence was below saturation levels. Neurons were randomly chosen and scanned at 512 x 512 pixel resolution.
###end p 28
###begin title 29
Statistical analysis
###end title 29
###begin p 30
###xml 207 215 205 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">post hoc</italic>
###xml 294 295 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Results are expressed as the means +/- S.E.M. Statistical analysis of data was performed using Graph Pad Prism version 4.0. Statistical significance was determined by oneway ANOVA between groups followed by post hoc Newman-Keuls test. Differences were considered statistically significant when P < 0.05.
###end p 30
###begin title 31
Results
###end title 31
###begin title 32
###xml 10 13 <span type="species:ncbi:10116">rat</span>
Purity of rat cortical neurons in primary culture
###end title 32
###begin p 33
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1A</xref>
###xml 23 26 <span type="species:ncbi:10116">rat</span>
The purity of cultured rat primary neurons was determined by monitoring morphology with phase contrast microscopy and by immunofluorescence assay with the neuron-specific marker NeuN and the nuclear stain, TO-PRO-3 (Figure 1A). NeuN staining was found primarily in the nucleus of the neurons with lighter staining in the cytoplasm. About 95% of the cells were determined to be cortical neurons based on the ratio of NeuN positive cells to total cells counted by TO-PRO nuclear staining (data not shown).
###end p 33
###begin p 34
###xml 54 55 54 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 189 196 189 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Panel a</italic>
###xml 229 236 229 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Panel b</italic>
###xml 263 270 263 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Panel c</italic>
###xml 383 386 383 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1&#8211;7</sub>
###xml 676 678 676 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RT</italic>
###xml 757 758 757 758 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 916 917 916 917 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 10 13 <span type="species:ncbi:10116">rat</span>
###xml 73 76 <span type="species:ncbi:10116">Rat</span>
###xml 157 162 <span type="species:ncbi:10090">mouse</span>
###xml 861 866 <span type="species:ncbi:9606">Human</span>
###xml 907 912 <span type="species:ncbi:9606">human</span>
Purity of rat primary cortical neurons (rPCNs) and P2X7R expression. (A) Rat PCNs were cultured on coverslips in 6-well plates and neurons were labeled with mouse NeuN monoclonal antibody (Panel a) and cell nuclei with TO-PRO-3 (Panel b); merged picture shown in Panel c. (B) RNA was isolated from rPCNs maintained in culture for 7-10 days and RT-PCR was used to amplify mRNAs to P2X1-7Rs, as described in the Materials and methods. The amplified PCR products were resolved by gel electrophoresis, and data shown are representative of results from three independent experiments. Results are shown of PCRs performed in the presence (+) or absence (-) of reverse transcriptase (RT). G3PDH primers were used to amplify G3PDH mRNA as a positive control. (C) P2X7R protein expression was detected by Western blot analysis, as described in the Materials and methods. Human 1321N1 cells expressing the recombinant human P2X7R or the empty expression vector pLXSN were used as positive (+) or negative (-) controls, respectively. Precision Plus Protein Standards are indicated as '75KD' and '100KD.'
###end p 34
###begin title 35
###xml 14 15 14 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 35 38 <span type="species:ncbi:10116">rat</span>
Functional P2X7Rs are expressed in rat PCNs
###end title 35
###begin p 36
###xml 20 21 20 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 53 54 53 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 59 60 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 65 66 65 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink">5</sub>
###xml 75 76 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1B</xref>
###xml 165 166 165 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1C</xref>
###xml 196 197 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 266 268 266 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 269 270 269 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 384 385 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 518 519 518 519 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 572 573 572 573 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 604 606 604 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 607 608 607 608 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 0 3 <span type="species:ncbi:10116">Rat</span>
Rat PCNs express P2X7R mRNA, as well as mRNAs for P2X2, P2X3, P2X5, and P2X6 receptors (Figure 1B). Furthermore, immunoblot analysis indicated that rPCNs express P2X7R protein (Figure 1C). The P2X7R agonists ATP and BzATP (35) caused a dose-dependent increase in [Ca2+]i in rPCNs (Figure 2), suggesting that calcium influx is stimulated by activation of the endogenously expressed P2X7R protein. Calcium responses were also observed by stimulation of rPCNs with 2-methylthio-ADP (data not shown), an agonist of the P2Y1R, indicating that other P2R subtypes besides the P2X7R can regulate increases in [Ca2+]i.
###end p 36
###begin p 37
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 153 154 153 154 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 303 305 303 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 306 307 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i</sub>
###xml 47 50 <span type="species:ncbi:10116">rat</span>
ATP- and BzATP-induced increases in [Ca2+]i in rat PCNs. (A) Single cell calcium assays were performed on rPCNs that were cultured for 7-10 days on poly-d-lysine-coated coverslips. Fura-2 loaded cells were incubated in PSS with the indicated concentration of BzATP or ATP and the maximum increase in [Ca2+]i was determined, as described in the Materials and methods. (B) The percentage of cells responding to BzATP or ATP is shown as the mean +/- S.E.M. of results from three experiments.
###end p 37
###begin title 38
ATP and BzATP induce nuclear condensation and DNA fragmentation in rPCNs
###end title 38
###begin p 39
###xml 166 167 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 229 230 221 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 287 288 279 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 412 413 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 573 574 565 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 674 675 666 667 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
Treatment of rPCNs with either BzATP (300 microM) or ATP (100 microM) overnight caused nuclear condensation as indicated by increased DAPI staining of nuclei (Figure 3). BzATP-induced nuclear condensation was inhibited by the P2X7R antagonist oATP, consistent with the involvement of P2X7Rs in this process. Moreover, BzATP treatment of rPCNs caused DNA fragmentation, suggestive of apoptotic cell death (Figure 4). BzATP or ATP also caused DNA strand breakage in rPCNs, another indicator of apoptosis, detected as an increase in the number of TUNEL-positive cells (Figure 5). These data suggest that BzATP or ATP can cause apoptosis in rPCNs through a pathway involving P2X7R activation.
###end p 39
###begin p 40
###xml 58 59 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 257 258 249 250 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 259 260 251 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 395 397 383 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NB</italic>
###xml 812 813 798 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 829 830 815 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 918 921 904 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink">###</sup>
###xml 921 922 907 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 103 106 <span type="species:ncbi:10116">Rat</span>
ATP/BzATP-induced nuclear condensation mediated by the P2X7R is dependent on caspase-3 activation. (A) Rat PCNs were cultured for 7-10 days, incubated in serum-free HGGMEM for 6 h and stimulated with BzATP (300 microM) or ATP (100 microM) for 16 h or with H2O2 (1 microM) for 2 h. When indicated, 500 mM oATP was added 2 h prior to addition of BzATP. Cells cultured in B27-AO Neurobasal medium (NB) or in serumfree HGGMEM (-) overnight were used as controls. Then, nuclear condensation was determined by DAPI staining and detected by fluorescence microscopy, as described in the Materials and methods. (B) Cells were treated as in (A) except that the data were expressed as a percentage of cells that exhibited DAPI stained nuclei. Data are the means +/- S.E.M. of results from at least four experiments, where *P < 0.05, and ***P < 0.001 indicate significant differences from the serum-starved control (-), and where ###P < 0.001 indicates a significant difference from BzATP treatment. (C) rPCNs were treated as in (A) except that 10 microM ZDEVD-FMK, a caspase-3 inhibitor, was added for 1 h prior to BzATP, when indicated.
###end p 40
###begin p 41
###xml 158 159 154 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 160 161 156 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 653 654 645 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">M</italic>
###xml 38 41 <span type="species:ncbi:10116">rat</span>
###xml 48 51 <span type="species:ncbi:10116">Rat</span>
BzATP stimulates DNA fragmentation in rat PCNs. Rat PCNs were incubated in serum-free HGGMEM for 6 h and then stimulated with BzATP (300 microM) for 16 h or H2O2 (1 mM) for 2 h. Cells cultured in serumfree HGGMEM (-) overnight were used as the control. Then, cells were lysed, total DNA was purified, the DNA concentration was determined, and 3 microg of purified DNA were loaded onto each lane of a 2% (w/v) agarose gel and electrophoresed, as described in the Materials and methods. DNAfragmentation was visualized after electrophoresis of DNA. Apoptotic U937 cells (+++; provided in the Apoptotic DNA-ladder kit) were used as a positive control and 'M' indicates the 100 bp DNA ladder marker.
###end p 41
###begin p 42
###xml 209 210 201 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 211 212 203 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 44 47 <span type="species:ncbi:10116">rat</span>
###xml 54 57 <span type="species:ncbi:10116">Rat</span>
BzATP or ATP induces DNA strand breakage in rat PCNs. Rat PCNs were cultured for 7-10 days, incubated in serum-free HGGMEM for 6 h, and stimulated with BzATP (300 microM) or ATP (100 microM) for 16 h or with H2O2 for 2 h. Cells cultured in serum-free HGGMEM (-) overnight were used as the control. Then, cells were fixed and DNA strand breakage was determined by TUNEL assay, as described in the Materials and methods. DNA strand breakage was observed as green fluorescence using fluorescence microscopy.
###end p 42
###begin title 43
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
P2X7R-mediated caspase-3 and caspase-9 activation
###end title 43
###begin p 44
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3C</xref>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6A</xref>
###xml 700 702 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6B</xref>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6B</xref>
###xml 759 760 759 760 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6C</xref>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">38</xref>
###xml 954 955 954 955 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1018 1019 1018 1019 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1361 1363 1361 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6D</xref>
###xml 1536 1538 1536 1538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">39</xref>
Caspase-3 is an essential component of apoptotic pathways in many cell types, including neurons [36], and is activated by the sequential release of cytochrome c from mitochondria dria and the activation of caspase-9 [37]. Consistent with a role for caspase-3 in nucleotide-induced neuronal apoptosis, nuclear condensation caused by BzATP was diminished by treatment of rPCNs with the caspase-3 inhibitor Z-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-FMK (Z-DEVDFMK; Figure 3C). Results also indicated that treatment of rPCNs with either ATP or BzATP significantly increased the cleavage of caspase-3 in a time- and dose-dependent manner (Figure 6A). BzATP-induced caspase-3 cleavage was inhibited by oATP (Figure 6B), the caspase-3 inhibitor Z-DEVD-FMK (Figure 6B), or P2X7 antisense oligonucleotide (Figure 6C). Although recent studies indicate that oATP might act independently from P2 receptor inhibition [38], inhibition of BzATP-induced caspase-3 cleavage by P2X7R antisense oligonucleotide confirms the involvement of the P2X7R. Since no preparation of primary neurons is devoid of glial cells, dual immunofluorescence analysis for neuron-specific NeuN and cleaved caspase-3 was performed to evaluate whether the apoptotic cells were neurons. The majority of cells treated with BzATP were positive for cleaved caspase-3 and NeuN (e.g., pink and white arrows in Figure 6D), indicating that a large percentage of cells undergoing apoptosis were neurons. NeuN immunoreactivity has been reported to decrease under several pathological conditions [39], and therefore NeuN detection may decrease with caspase-3 activation in apoptotic neurons, suggesting that some apoptotic neurons may go undetected.
###end p 44
###begin p 45
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 534 535 522 523 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 685 686 669 670 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 687 688 671 672 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 855 856 839 840 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 948 949 930 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 960 961 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 977 978 959 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1112 1123 1094 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Panels B, D</italic>
###xml 1128 1129 1110 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1144 1155 1126 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Panels A, C</italic>
###xml 1161 1162 1143 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 1244 1262 1226 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">green; Panels A, B</italic>
###xml 1284 1297 1266 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">red; Panels C</italic>
###xml 1302 1303 1284 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1336 1350 1318 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">blue; Panels E</italic>
###xml 1355 1356 1337 1338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1416 1422 1398 1404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arrows</italic>
###xml 1424 1437 1406 1419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pink or white</italic>
###xml 1517 1530 1499 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yellow arrows</italic>
###xml 39 42 <span type="species:ncbi:10116">rat</span>
###xml 53 56 <span type="species:ncbi:10116">Rat</span>
###xml 1057 1060 <span type="species:ncbi:10116">Rat</span>
P2X7Rs mediate caspase-3 activation in rat PCNs. (A) Rat PCNs were incubated in serum-free HGGMEM for 6 h and then the indicated concentration of ATP or BzATP was added for 16 h or the time indicated. Cells cultured in serum-free HGGMEM (-) overnight were used as controls. (B) Cells were treated as in (A) except that 500 microM oATP was added for 2 h or the indicated concentration (1, 10 or 100 microM) of Z-DEVD-FMK was added for 1 h prior to addition of 300 microM BzATP for 16 h. (C) Cells were treated as in (A) except that P2X7 antisense or sense oligonucleotide was added at the indicated concentration in mg/ml for 8 h prior to addition of 300 microM BzATP for 16 h or 1 mM H2O2 for 2 h. Western analysis was performed as described in Materials and methods to determine the relative amounts of full length pan caspase-3, cleaved caspase-3 or P2X7R protein. Data are the means +/- S.E.M. of results from at least three experiments, where *P < 0.05, **P < 0.01, and ***P < 0.001 indicate significant differences from BzATP-treated (B, C) cells. (D) Rat PCNs were serum-starved overnight in the presence (Panels B, D and F ) or absence (Panels A, C, and E) of 300 mM BzATP and then immunofluorescence of the neuron-specific marker NeuN (green; Panels A, B), cleaved caspase-3 (red; Panels C and D), and the nuclear stain TO-PRO (blue; Panels E and F ) were detected as described in the Materials and methods. Arrows (pink or white) indicate apoptotic neurons that are both caspase-3 and NeuN positive, whereas yellow arrows indicate apoptosis in a NeuN-negative cell. Similar results were obtained in three individually isolated groups of cells.
###end p 45
###begin p 46
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig7" ref-type="fig">7A</xref>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig7" ref-type="fig">7B</xref>
###xml 361 362 361 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig7" ref-type="fig">7C</xref>
BzATP also caused the cleavage of caspase-9 (Figure 7A), whereas activation of caspase-9 and caspase-3 were significantly inhibited by the caspase-8 inhibitor Ac-IETD-CHO (Figure 7B) or the caspase-9 inhibitor Z-LEHD-FMK (data not shown), indicating that caspase-8 also plays a role in activating downstream caspase family members (i.e., caspase-9/3) of the P2X7R-mediated apoptosis pathway. We also detected an inhibitory effect of the caspase-9 inhibitor, Z-LEHD-FMK, on caspase-8 cleavage (Figure 7C) suggesting that caspase-8 and caspase-9 may regulate caspase-3 activity in a non-linear fashion.
###end p 46
###begin p 47
###xml 38 39 38 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 789 790 775 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 801 802 787 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 818 819 804 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 74 77 <span type="species:ncbi:10116">Rat</span>
Role of caspase-8 and caspase-9 in P2X7R-mediated apoptosis in rPCNs. (A) Rat PCNs were incubated in serum-free HGGMEM and BzATP (300 microM) was added for 16 h. Cells cultured in B27-AO Neurobasal medium (NB) or in serum-free HGGMEM (-) overnight were used as controls. (B) Cells were treated as in (A) except that the indicated concentration (microM) of a specific caspase-8 inhibitor, Ac-IETDCHO was added for 1 h prior to addition of 300 microM BzATP. (C) Cells were treated as in (B) except that the indicated concentration of a specific caspase-9 inhibitor, Z-LEHD-FMK, was added. 'Pan' ( full-length) and cleaved caspase-8 were detected by Western analysis, as described in the Materials and methods. Data are the means +/- S.E.M. of results from at least three experiments, where *P < 0.05, **P < 0.01, and ***P < 0.001 indicate significant differences from either serum-starved (A) or BzATPtreated (B, C) cells.
###end p 47
###begin title 48
Caspase-3 activation by BzATP in rPCNs is dependent upon ERK1/2 or JNK1 phosphorylation
###end title 48
###begin p 49
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">40</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">41</xref>
###xml 364 365 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig8" ref-type="fig">8</xref>
###xml 741 742 741 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig9" ref-type="fig">9</xref>
###xml 80 83 <span type="species:ncbi:10116">rat</span>
###xml 124 129 <span type="species:ncbi:9606">human</span>
P2X7R-mediated activation of extracellular signal-regulated kinases (ERK1/2) in rat primary astrocytes [40] and SAPK/JNK in human and rodent macrophages occur independently of the activation of caspase-1- or caspase- 3-like proteases [41]. Here, we tested whether ERK1/2 or JNK1 activities were involved in BzATP-induced apoptosis in rPCNs. As indicated in Figure 8, both ERK1/2 and JNK1 were rapidly phosphorylated in response to BzATP or ATP in a dose- and time-dependent manner. Inhibition of ERK1/2 or JNK1 phosphorylation in rPCNs with either the MEK inhibitor UO126 or the JNK inhibitor SP600125, respectively, attenuated caspase-3 activation, indicating the involvement of ERK1/2 and JNK1 in BzATP-induced neuronal cell death (Figure 9).
###end p 49
###begin p 50
###xml 63 66 <span type="species:ncbi:10116">Rat</span>
BzATP or ATP induces ERK1/2 and JNK1 phosphorylation in rPCNs. Rat PCNs were incubated in serum-free HGGMEM for 6 h and treated with the indicated concentration (microM) of BzATP or ATP for 5 min or with 100 microM ATP or 300 microM BzATP for the indicated time period. Cells cultured in serum-free HGGMEM (-) overnight were used as the control. Then, cell lysates were prepared and (A) ERK1/2 or (B) JNK1 phosphorylation was detected by Western analysis, as described in the Materials and methods. Total ERK1/2 and actin were used as protein loading controls for (A) and (B), respectively.
###end p 50
###begin p 51
###xml 635 636 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 647 648 641 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 664 665 658 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 71 74 <span type="species:ncbi:10116">rat</span>
###xml 81 84 <span type="species:ncbi:10116">Rat</span>
Inhibitors of MEK and JNK decrease BzATP-induced caspase-3 cleavage in rat PCNs. Rat PCNs were incubated in serum-free HGGMEM for 6 h and treated for 30 min with the indicated concentration (microM) of (A) the MEK inhibitor U0126, (B) the JNK inhibitor SP600125 or (A, B) 0.1% (v/v) DMSO as a vehicle control. Then, the cells were incubated with 300 mM BzATP for 16 h, and Western analysis was used to detect cleaved or pan caspase-3, as described in the Materials and methods. Cells cultured in serum-free HGGMEM (-) overnight were used as the control. Data are the means +/- S.E.M. of results from at least three experiments, where *P < 0.05, **P < 0.01, and ***P < 0.001 indicate significant differences from BzATP-treated cells.
###end p 51
###begin title 52
Discussion
###end title 52
###begin p 53
###xml 70 71 70 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 373 374 373 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR42">42</xref>
###xml 413 414 413 414 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 515 516 515 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 540 541 540 541 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 599 600 599 600 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 677 678 677 678 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 704 705 704 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 751 752 751 752 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 788 789 788 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 906 908 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3C</xref>
###xml 913 915 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6B</xref>
###xml 954 955 954 955 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 26 29 <span type="species:ncbi:10116">rat</span>
The results obtained with rat PCNs indicate that activation of the P2X7R by its agonists BzATP or ATP promotes the cleavage of caspases-8/9/3 and the appearance of cellular markers indicative of apoptosis including DNA degradation and nuclear condensation and fragmentation. Since BzATP can activate other P2X receptor subtypes, albeit at higher concentrations than the P2X7R [42], we explored the role of the P2X7R in the apoptotic effects of BzATP in rPCNs using P2X7 antisense oligonucleotide to downregulate P2X7R expression and the P2X7R antagonist oATP. Results indicate that inhibition of P2X7R activity significantly inhibited BzATP-induced nuclear condensation (by P2X7R antagonist oATP; Figure 3) and caspase-3 cleavage (by both oATP and P2X7R antisense oligonucleotide; Figure 6), apoptotic responses that were diminished by incubation of rPCNs with the caspase-3 inhibitor, Z-DEVD-FMK (Figures 3C and 6B). These data strongly suggest that P2X7Rs mediate BzATP-induced apoptosis in rPCNs, although this does not rule out a potential role for other P2 nucleotide receptors.
###end p 53
###begin p 54
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 178 179 178 179 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 299 300 299 300 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 553 554 553 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR43">43</xref>
###xml 850 851 850 851 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 905 912 905 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 953 954 953 954 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1001 1003 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR44">44</xref>
###xml 1052 1053 1052 1053 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1120 1121 1120 1121 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1205 1206 1205 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 1229 1237 1229 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1291 1292 1291 1292 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 976 979 <span type="species:ncbi:10116">rat</span>
P2X7R-mediated neuronal apoptosis in vivo requires that ATP be released from neurons or non-neuronal cells to activate cell surface receptors on neighboring neurons. Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems and activation of the P2X7R has been indicated to promote release of vesicular contents from presynaptic terminals [20]. ATP is present at high concentrations in synaptic vesicles and is released as a co-transmitter with noradrenaline, acetylcholine and other neurotransmitters [1]. ATP release also has been demonstrated in a model of spinal cord injury [43]. Thus, ATP release from excited neurons or damaged cells is an assumed consequence of any brain injury or disease (e.g., ischemia, spinal cord injury, or neurodegenerative diseases), suggesting that pro-apoptotic P2X7Rs are likely activated under pathological conditions in vivo. Recent research indicates a lack of P2X7R expression in adult rat hippocampal neurons [44], whereas our studies demonstrate functional P2X7R expression in rPCNs from 18-day old embryos. We have detected P2X7R mRNA in freshly isolated rPCNs (data not shown) and 7-10 day-old cultures (Figure 1), suggesting that the in vitro cell culture procedure alone was not required for P2X7R expression.
###end p 54
###begin p 55
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig7" ref-type="fig">7B</xref>
###xml 982 984 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR45">45</xref>
###xml 1062 1064 1062 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR46">46</xref>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR47">47</xref>
###xml 1406 1408 1406 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR47">47</xref>
###xml 1409 1411 1409 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR51">51</xref>
###xml 1470 1471 1470 1471 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1619 1621 1619 1621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 1835 1843 1835 1843 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1964 1966 1964 1966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR52">52</xref>
###xml 1967 1969 1967 1969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR54">54</xref>
###xml 2066 2068 2066 2068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig7" ref-type="fig">7C</xref>
###xml 696 699 <span type="species:ncbi:10116">rat</span>
###xml 1417 1422 <span type="species:ncbi:9606">human</span>
Caspase activation is known to play a central role in the execution of apoptosis by causing nuclear condensation, DNA fragmentation and other apoptotic changes. In the mitochondrial-initiated pathway of apoptosis, caspase activation is triggered by the formation of a multimeric Apaf-1/cytochrome c complex that is fully functional in recruiting and activating procaspase-9 [37]. Activated caspase-9 will then cleave and activate downstream caspases such as caspase-3, -6, and -7. In rPCNs, it was not surprising that activation of caspase-3 was significantly inhibited by the caspase-9 inhibitor Z-LEHD-FMK (data not shown), since caspase-9 is known to activate caspase-3. We also found that in rat PCNs, the caspase-8 inhibitor Ac-IETD-CHO partially inhibited caspase-9 and caspase-3 activation (Figure 7B) indicating that caspase-8 cleavage may be an early event in this neuronal apoptosis pathway. Caspase-8 has been reported to play a role in cytochrome c-dependent apoptosis [45] and caspase-8 activation is associated with Fas receptor-induced apoptosis [46] and can result in the cleavage and activation of Bid, a proapoptotic member of the Bcl-2 family [47]. Truncated Bid translocates from the cytoplasm to the mitochondria, where it appears to antagonize the actions of anti-apoptotic Bcl-2, thereby causing an efflux of cytochrome c from the mitochondria and downstream caspase-9/3 activation [47-51]. In human embryonic kidney (HEK) 293 cells expressing P2X7Rs, extracellular ATP induced apoptosis associated with activation of poly (ADP-ribose) polymerase (PARP) and a decrease in Bax protein expression [29]. We examined the effect of ATP/BzATP on the expression of Bcl-2 family members in rPCNs but failed to detect a significant change in Bax and Bcl-2 protein expression (data not shown). Evidence from cell-free and in vitro expression systems has indicated that caspase-3 can induce cleavage and activation of the upstream initiator caspase-8 [52-54]. Our data indicated that inhibition of caspase-9 cleavage decreased caspase-8 cleavage (Figure 7C), consistent with the ability of downstream caspases to regulate the cleavage of initiator caspases.
###end p 55
###begin p 56
###xml 43 44 43 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig8" ref-type="fig">8</xref>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig9" ref-type="fig">9</xref>
###xml 336 337 336 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 399 401 399 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR55">55</xref>
###xml 483 484 483 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR56">56</xref>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR57">57</xref>
###xml 875 876 875 876 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
We have demonstrated that activation of P2X7Rs in rPCNs increases calcium influx (Figure 2) and stimulates phosphorylation of the intracellular kinases ERK1/2 and JNK1 (Figure 8). Furthermore, inhibition of ERK1/2 or JNK1 phosphorylation decreased BzATP-induced caspase-3 cleavage (Figure 9). Our previous studies demonstrating that P2X7R-mediated ERK1/2 activation was dependent on extracellular Ca2+ [55] suggest a similar role for BzATP-stimulated calcium influx in rPCNs (Figure 2). Recent studies indicate that activation of ERK and phosphatidylinositol 3-kinase/Akt signaling pathways caused inhibition of caspase-3 and cell apoptosis [56]. It also has been reported that inhibition of MEK/ERK signaling is required for the induction of apoptosis by Sulindac metabolites [57]. Nonetheless, our data support the hypothesis that ERK1/2 and JNK1 activation can promote P2X7R-mediated apoptosis in rPCNs, although the mechanism involved requires further investigation.
###end p 56
###begin p 57
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR58">58</xref>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR59">59</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR60">60</xref>
###xml 366 367 366 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 467 469 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR58">58</xref>
###xml 506 507 503 504 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 526 528 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR61">61</xref>
###xml 595 596 592 593 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 737 738 734 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 941 943 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR62">62</xref>
###xml 982 983 979 980 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1323 1324 1320 1321 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 1359 1361 1356 1358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR63">63</xref>
P2X7Rs can promote neuronal cell death by mediating the release of glutamate and inflammatory factors from cells including astrocytes [18, 58, 59]. Moreover, glutamate can induce ATP release from astrocytes [60], suggesting that ATP and glutamate have reciprocal roles that contribute to the propagation of an apoptotic signal. It also has been reported that the P2X7R modulates macrophage production of TNF-ga, IL-1beta and nitric oxide (NO) following LPS exposure [58], consistent with a role for the P2X7R in inflammation [61]. In addition to these factors, structural features within the P2X7R indicate that the mechanism whereby it regulates apoptosis is likely to be complex. There are several functional domains located in the P2X7R C-terminal tail including an LPS-binding domain, a SH3-binding domain, and an overlapping Fcelldeath_ domain, which appear to be important for receptor trafficking and various physiological functions [62], and the role of these domains in P2X7R-mediated apoptosis of neurons warrants further investigation. Our studies with the membrane impermeant fluorescent dye YO-PRO-1 (molecular weight: 375 Da) indicate that BzATP causes pore formation (YO-PRO-1 uptake) in rPCNs (data not shown), consistent with the report that apoptosis in the retinal microvasculature is associated with P2X7 receptor-mediated pore formation [63].
###end p 57
###begin p 58
###xml 79 80 79 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 226 228 226 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 557 558 557 558 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 596 597 596 597 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR64">64</xref>
###xml 674 675 674 675 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 620 625 <span type="species:ncbi:10090">mouse</span>
A recent study indicated that spinal cord neurons expressed an abundance of P2X7Rs, and exposure of freshly prepared spinal cord slices to ATP or BzATP evoked highfrequency firing and irreversible increases in the cytosolic Ca2+ concentration [31]. Significant cell death occurred 24 h after spinal cord injury in areas of high ATP release surrounding the epicenter of the injury, while local injection of oATP in the peritraumatic zone strongly reduced both apoptotic cell number and the severity of histological injury, suggesting the involvement of a P2X7R. Other studies indicate that the P2X7R is up-regulated in a mouse model of Alzheimer's disease [64]. Thus, the P2X7R may represent a promising therapeutic target to inhibit neurodegeneration due to injury or disease.
###end p 58
###begin p 59
###xml 76 77 76 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 481 482 481 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 93 96 <span type="species:ncbi:10116">rat</span>
In summary, the data presented indicate that BzATP and ATP can stimulate P2X7Rs in embryonic rat primary cortical neurons leading to the activation of the caspases-8/9/3 and the induction of DNA degradation and nuclear condensation and fragmentation, apoptotic responses that appear to be regulated by ERK1/2 and JNK1. Since neuronal apoptosis occurs in Alzheimer's disease, Parkinson's disease and other neurodegenerative disorders, a better understanding of the mechanisms of P2X7R-mediated apoptosis may lead to novel therapies to prevent apoptosis-related brain injuries.
###end p 59
###begin title 60
Acknowledgements
###end title 60
###begin p 61
We sincerely thank Xiaolin Zhang, Jennifer Aufder Heide, and the University of Missouri-Columbia Molecular Cytology Core Facility for excellent technical assistance. This study was supported by National Institutes of Health Grants 1 P01-AG18357 and 1 P20-RR15565, the University of Missouri-Columbia Food for the 21st Century Program, and the University of Missouri-Columbia Neuroscience Program (fellowship to Q. Kong).
###end p 61
###begin title 62
References
###end title 62
###begin article-title 63
###xml 97 107 <span type="species:ncbi:10141">guinea-pig</span>
Direct evidence for ATP release from non-adrenergic, non-cholinergic ("purinergic- nerves in the guinea-pig taenia coli and bladder
###end article-title 63
###begin article-title 64
Purinergic nerves and receptors
###end article-title 64
###begin article-title 65
Microglial activation by purines and pyrimidines
###end article-title 65
###begin article-title 66
###xml 66 68 66 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink">14</sub>
Characterization of the UDP-glucose receptor (renamed here the P2Y14 receptor) adds diversity to the P2Y receptor family
###end article-title 66
###begin article-title 67
P2X receptors in sensory neurones
###end article-title 67
###begin article-title 68
Neuronal P2X receptors: localisation and functional properties
###end article-title 68
###begin article-title 69
Molecular pharmacology of P2Y-receptors
###end article-title 69
###begin article-title 70
International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits
###end article-title 70
###begin article-title 71
Neuronal P2 receptors of the central nervous system
###end article-title 71
###begin article-title 72
ATP-gated channels in vascular smooth muscle cells
###end article-title 72
###begin article-title 73
Nucleotide receptors: an emerging family of regulatory molecules in blood cells
###end article-title 73
###begin article-title 74
###xml 56 57 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
Cloning and functional characterisation of the mouse P2X7 receptor
###end article-title 74
###begin article-title 75
Pharmacology of cloned P2X receptors
###end article-title 75
###begin article-title 76
###xml 15 17 15 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2Z</sub>
###xml 82 83 82 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7)
###end article-title 76
###begin article-title 77
###xml 36 37 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 67 72 <span type="species:ncbi:9606">human</span>
The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA
###end article-title 77
###begin article-title 78
###xml 30 31 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
Tissue distribution of the P2X7 receptor
###end article-title 78
###begin article-title 79
Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin
###end article-title 79
###begin article-title 80
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
P2X7 receptor-mediated release of excitatory amino acids from astrocytes
###end article-title 80
###begin article-title 81
###xml 99 102 <span type="species:ncbi:10116">rat</span>
Confocal calcium imaging reveals an ionotropic P2 nucleotide receptor in the paranodal membrane of rat Schwann cells
###end article-title 81
###begin article-title 82
###xml 12 13 12 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems
###end article-title 82
###begin article-title 83
###xml 117 120 <span type="species:ncbi:10116">rat</span>
Differential co-localisation of the P2X7 receptor subunit with vesicular glutamate transporters VGLUT1 and VGLUT2 in rat CNS
###end article-title 83
###begin article-title 84
Cellular responses to external ATP which precede an increase in nucleotide permeability in transformed cells
###end article-title 84
###begin article-title 85
###xml 91 92 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 84 87 <span type="species:ncbi:10116">rat</span>
Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor
###end article-title 85
###begin article-title 86
###xml 17 19 17 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 52 55 <span type="species:ncbi:10116">rat</span>
Stimulation of Ca2+ influx through ATP receptors on rat brain synaptosomes: identification of functional P2X7 receptor subtypes
###end article-title 86
###begin article-title 87
###xml 83 86 <span type="species:ncbi:10116">rat</span>
Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus
###end article-title 87
###begin article-title 88
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Lack of ATP-evoked GABA and glutamate release in the hippocampus of P2X7 receptor-mice
###end article-title 88
###begin article-title 89
###xml 12 13 12 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
Synaptic P2X7 and oxygen/glucose deprivation in organotypic hippocampal cultures
###end article-title 89
###begin article-title 90
###xml 65 66 65 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 133 139 <span type="species:ncbi:10090">murine</span>
The Pro-451 to Leu polymorphism within the C-terminal tail of P2X7 receptor impairs cell death but not phospholipase D activation in murine thymocytes
###end article-title 90
###begin article-title 91
###xml 163 164 163 164 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 133 138 <span type="species:ncbi:9606">human</span>
Poly(ADP-ribose) polymerase activation and changes in Bax protein expression associated with extracellular ATP-mediated apoptosis in human embryonic kidney 293-P2X7 cells
###end article-title 91
###begin article-title 92
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 36 41 <span type="species:ncbi:9606">human</span>
P2X7 receptor-mediated apoptosis of human cervical epithelial cells
###end article-title 92
###begin article-title 93
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
P2X7 receptor inhibition improves recovery after spinal cord injury
###end article-title 93
###begin article-title 94
Reduction of calcium release from the endoplasmic reticulum could only provide partial neuroprotection against beta-amyloid peptide toxicity
###end article-title 94
###begin article-title 95
Fluorescent complexes of DNA with DAPI 4-6-diamidine-2-phenyl indole.2HCl or DCI 4-6-dicarboxyamide-2-phenyl indole
###end article-title 95
###begin article-title 96
###xml 28 29 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
Covalent incorporation of 3-O-(4-benzoyl)benzoyl-ATP into a P2 purinoceptor in transformed mouse fibroblasts
###end article-title 96
###begin article-title 97
Caspases: intracellular signaling by proteolysis
###end article-title 97
###begin article-title 98
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
###end article-title 98
###begin article-title 99
Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms
###end article-title 99
###begin article-title 100
Loss of NeuN immunoreactivity after cerebral ischemia does not indicate neuronal cell loss: A cautionary note
###end article-title 100
###begin article-title 101
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase
###end article-title 101
###begin article-title 102
###xml 92 93 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor
###end article-title 102
###begin article-title 103
###xml 48 53 <span type="species:ncbi:9606">human</span>
###xml 58 61 <span type="species:ncbi:10116">rat</span>
Pharmacological characterization of recombinant human and rat P2X receptor subtypes
###end article-title 103
###begin article-title 104
###xml 17 18 17 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
Reanalysis of P2X7 receptor expression in rodent brain
###end article-title 104
###begin article-title 105
Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury
###end article-title 105
###begin article-title 106
Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease
###end article-title 106
###begin article-title 107
Caspase-8 mediates caspase-3 activation and cytochrome c release during singlet oxygen-induced apoptosis of HL-60 cells
###end article-title 107
###begin article-title 108
Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
###end article-title 108
###begin article-title 109
Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c
###end article-title 109
###begin article-title 110
Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
###end article-title 110
###begin article-title 111
Ion channel activity of the BH3 only Bcl-2 family member, BID
###end article-title 111
###begin article-title 112
Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death
###end article-title 112
###begin article-title 113
Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner
###end article-title 113
###begin article-title 114
Suicidal tendencies: Apoptotic cell death by caspase family proteinases
###end article-title 114
###begin article-title 115
Caspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis
###end article-title 115
###begin article-title 116
###xml 17 18 17 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 63 68 <span type="species:ncbi:9606">human</span>
Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells
###end article-title 116
###begin article-title 117
###xml 90 95 <span type="species:ncbi:9606">human</span>
Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils
###end article-title 117
###begin article-title 118
###xml 111 119 111 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 86 91 <span type="species:ncbi:9606">human</span>
Inhibition of extracellular-signal regulated kinases 1/2 is required for apoptosis of human colon cancer cells in vitro by Sulindac metabolites
###end article-title 118
###begin article-title 119
Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages
###end article-title 119
###begin article-title 120
Purinergic receptor regulation of LPS-induced signaling and pathophysiology
###end article-title 120
###begin article-title 121
###xml 52 55 <span type="species:ncbi:10116">rat</span>
A study of the mechanism of the release of ATP from rat cortical astroglial cells evoked by activation of glutamate receptors
###end article-title 121
###begin article-title 122
On the role of the P2X7 receptor in the immune system
###end article-title 122
###begin article-title 123
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide
###end article-title 123
###begin article-title 124
###xml 18 19 18 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
Enhancement of P2X7-induced pore formation and apoptosis: an early effect of diabetes on the retinal microvasculature
###end article-title 124
###begin article-title 125
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease
###end article-title 125
###begin article-title 126
###xml 14 15 14 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 109 115 <span type="species:ncbi:9986">rabbit</span>
Functional P2Y2 nucleotide receptors mediate uridine s'-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries
###end article-title 126
###begin title 127
Abbreviations
###end title 127
###begin p 128
adenosine 5-triphosphate
###end p 128
###begin p 129
###xml 4 5 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
2-3-O-(4-benzoylbenzoyl)-ATP
###end p 129
###begin p 130
intracellular free calcium concentration
###end p 130
###begin p 131
extracellular signal-regulated protein kinase
###end p 131
###begin p 132
###xml 8 9 8 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
c-Jun NH2-terminal kinase
###end p 132
###begin p 133
mitogen-activated protein kinase
###end p 133
###begin p 134
oxidized ATP
###end p 134
###begin p 135
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
P2Y2 nucleotide receptor
###end p 135
###begin p 136
###xml 3 4 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">7</sub>
P2X7 nucleotide receptor
###end p 136
###begin p 137
phosphate buffered saline
###end p 137
###begin p 138
protein kinase C
###end p 138
###begin p 139
###xml 0 3 <span type="species:ncbi:10116">rat</span>
rat primary cortical neurons
###end p 139
###begin p 140
reverse transcriptase-polymerase chain reaction
###end p 140
###begin p 141
Src-homology-3
###end p 141
###begin p 142
non-receptor tyrosine kinase
###end p 142
###begin p 143
tumor necrosis factor-alpha
###end p 143

